Target intelligence / Profile preview

Streptococcal glucosyltransferase and adhesion-related structures (GTF/AgI/II)

Target
GTF/AgI/II
Molecular classification
Enzyme, Adhesion protein, Virulence factor
01

Overview

Streptococcal glucosyltransferases (GTFs) and adhesion-related structures are primary virulence factors of cariogenic bacteria, particularly Streptococcus mutans, essential for the formation of dental plaque (Bowen & Koo, 2011). GTFs are extracellular enzymes that synthesize sticky glucan polymers from dietary sucrose, providing the physical matrix for biofilm development and facilitating bacterial accumulation on teeth (Krzyściak et al., 2014). Adhesion-related structures, such as the Antigen I/II (AgI/II) protein family, mediate the initial, high-affinity binding of streptococci to the salivary pellicle coating the tooth surface (Ma et al., 2015). By targeting these components, therapeutic agents aim to prevent the establishment of pathogenic biofilms and the subsequent localized acid production that causes tooth decay. Current pharmacological approaches include the use of monoclonal antibodies like CaroRx to block adhesion and small-molecule inhibitors or natural polyphenols to disrupt GTF activity (Lynch, 2011). These "anti-virulence" strategies are advantageous as they reduce the pathogenicity of the oral flora without the selective pressure for antibiotic resistance associated with traditional bactericidal agents.

Other names
Glucosyltransferase (GTF)Antigen I/II (AgI/II)P1 proteinSpaPPacBiofilm-associated proteinsStreptococcal adhesins
02

Mechanism of action

Inhibition of glucosyltransferase enzyme activity to prevent glucan synthesis and blocking of adhesion-related proteins to prevent bacterial attachment to the salivary pellicle.

03

Biological functions

Biofilm formationBacterial adhesionCarbohydrate metabolismExtracellular matrix synthesis
04

Disease associations

InfectionDental cariesInfective endocarditis
05

Safety considerations

Disruption of the commensal oral microbiome (dysbiosis)Topical oral irritationPotential for tooth staining with certain inhibitorsLimited systemic exposure concerns due to topical application
06

Interacting drugs

Chlorhexidine

5 more in the full profile.

07

Biomarkers

Streptococcus mutans colony forming units (CFU)Extracellular polysaccharide (EPS) concentrationPlaque pH levelsGlucan synthesis rate

Beyond the preview

Go deeper on Streptococcal glucosyltransferase and adhesion-related structures (GTF/AgI/II).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcal glucosyltransferase and adhesion-related structures (GTF/AgI/II).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call